JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
SER Financials - Serina Therapeutics Income & Cash Flow | Ledgeburg
SER - Serina Therapeutics, Inc.
USD | NYSE | Healthcare
Summary
Summary SER Stock
Financials
Financials SER Stock
Loading...
Loading...
Income Statement
Income Statement SER Stock
Balance Sheet
Balance Sheet SER Stock
Cash Flow Statement
Cash Flow Statement SER Stock
Loading...
Loading...
Home
Stocks
Serina Therapeutics, Inc. (SER)
Financials
Financials of SER
Loading...
Loading...
Loading...
Loading...
Revenue
$130K
Operating Income
$-24.022M
Net Income
$-19.215M
Share Count (Basic)
10.19M
Operating Cash Flow
$-17.955M
Free Cash Flow
$-18.014M
Cash And Short-Term Equivalents
$3.056M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
1M
2M
3M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50K
100K
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
-20M
-15M
-10M
-5M
0
5M
Annual
Quarterly
Margins
Gross
Operating
Net
-30000%
-20000%
-10000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-7M
-6M
-5M
-4M
-3M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-5000%
-4800%
-4600%
-4400%
-4200%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26